Prot# XPF-008-201: A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 as Adjunctive Therapy in Focal-onset Epilepsy

Project: Research project

Project Details

StatusFinished
Effective start/end date11/19/19 → 11/18/22

Funding

  • NCGS, Inc. (Prot# XPF-008-201)
  • Xenon Pharmaceuticals Inc. (Prot# XPF-008-201)